By the end of 2022, GEODIS had received the IATA CEIV Pharma certification in 7 additional sites in EUROPE on top of the already existing site in Amsterdam, Netherlands.
Having this certification ensures that facilities, equipment, operations and staff comply with the appropriate applicable standards, guidelines and regulations expected from a pharmaceutical manufacturer. This industry-wide standard aims to extend industry best practice and achieve a globally acceptable standardization. By forming a common baseline from existing regulation and standards, this certification ensures international and national compliance to safeguard product integrity while addressing specific air cargo needs in pharma logistics.
Pharma projects for GEODIS are looking extremely promising entering 2023 and will benefit further from IATA CEIV certification at the following sites in the EUROPE region: London, UK; Manchester, UK; Frankfurt, Germany; Arlanda, Sweden; Budapest, Hungary; Warsaw, Poland; Brussels, Belgium; and the already validated site in Amsterdam, Netherlands, which gained certification in December, 2021.
Thomas Kraus, GEODIS’ President & CEO of the EUROPE Region said, “Having 8 sites CEIV-certified within 1 year demonstrates the commitment of the EUROPE Region of GEODIS to pharma logistics excellence. Our goal is to be an essential part of the growing GEODIS pharma network worldwide for the sole benefit of our pharma customers and the patients using their products.”
GEODIS – www.geodis.com
GEODIS is a leading global logistics provider acknowledged for its expertise across all aspects of the supply chain. As a growth partner to its clients, GEODIS specializes in five lines of business: Supply Chain Optimization, Freight Forwarding, Contract Logistics, Distribution & Express, and Road Transport. With a global network spanning nearly 170 countries and more than 44,000 employees, GEODIS is ranked no. 7 in its sector across the world. In 2021, GEODIS generated €10.9 billion in revenue.